Medicine and Dentistry
Adenocarcinoma
12%
Aspiration
9%
Benign Tumor
15%
Biopsy
30%
Cancer
82%
Carcinoma
11%
Cylindroma
12%
Cytodiagnosis
13%
Cytopathology
75%
Cytotechnology
99%
Diagnosis
71%
Diagnostic Accuracy
11%
Differential Diagnosis
16%
Epidermal Growth Factor Receptor
9%
Fine-Needle Aspiration
100%
Head and Neck Squamous Cell Carcinoma
21%
Histopathology
9%
Immunohistochemistry
39%
in Situ Hybridization
20%
Lung Adenocarcinoma
25%
Lymph Node
10%
Malignant Neoplasm
16%
Malignant Pleural Effusion
15%
Metastatic Carcinoma
12%
Molecular Imaging
10%
Molecular Profiling
13%
Morphology
14%
Neck
14%
Neoplasm
63%
Nesidioblastosis
17%
Neuroendocrine Tumor
13%
Nodular Melanoma
9%
Non Small Cell Lung Cancer
19%
P16
22%
Papanicolaou Stain
17%
Patient Care
9%
Pleura Effusion
15%
Recurrent Disease
11%
Retrospective Study
11%
Salivary Gland
86%
Salivary Gland Disease
21%
Salivary Gland Neoplasm
42%
Small Cell Lung Cancer
9%
Small-Cell Carcinoma
15%
Squamous Cell
11%
Squamous Cell Carcinoma
18%
Surgery
10%
Synapsin I
17%
Thyroid Gland
20%
Wart Virus
60%
Keyphrases
Ancillary
11%
Atypia
9%
Atypia of Undetermined Significance
13%
Benign Neoplasm
13%
Core Needle Biopsy
16%
Cytological Features
22%
Cytological Samples
39%
Cytomorphology
22%
Cytopathology
21%
Diagnostic Accuracy
9%
Diagnostic Categories
10%
Diagnostic Challenge
9%
Diagnostic pitfalls
13%
Diagnostic Tool
9%
Differential Diagnosis
15%
Fine-needle Aspiration
59%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
21%
High-risk Human Papillomavirus (HR-HPV)
43%
Histology
10%
Human Papillomavirus Testing
10%
Immunohistochemistry
18%
Immunostain
15%
Insulinoma-associated Protein 1 (INSM1)
17%
Johns Hopkins Hospital
10%
Lung
11%
Lung Adenocarcinoma
10%
Malignancy
15%
Malignant Pleural Effusion
15%
Milan System
15%
Milan System for Reporting Salivary Gland Cytopathology (MSRSGC)
36%
Molecular Alterations
10%
Molecular Profiling
13%
Multi-institutional Study
39%
Non-neoplastic
12%
Non-small Cell Lung Cancer (NSCLC)
13%
Nondiagnostic
9%
Patient Demographics
10%
Pleomorphic Adenoma
9%
Preanalytical Factors
8%
Pulmonary Adenocarcinoma
13%
Risk of Malignancy
35%
Salivary Duct Carcinoma
9%
Salivary Gland
29%
Salivary Gland Lesions
10%
Salivary Gland Neoplasm of Uncertain Malignant Potential
20%
Salivary Gland Neoplasms
15%
Small Cell Carcinoma
15%
Surgical Specimen
9%
Suspicious for Malignancy
16%
Tumor
17%